1. Home
  2. SRI vs PLX Comparison

SRI vs PLX Comparison

Compare SRI & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$7.84

Market Cap

161.7M

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.92

Market Cap

168.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
PLX
Founded
1965
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
168.1M
IPO Year
1997
1998

Fundamental Metrics

Financial Performance
Metric
SRI
PLX
Price
$7.84
$2.92
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$16.00
$12.00
AVG Volume (30 Days)
159.5K
1.2M
Earning Date
02-25-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$874,357,000.00
$61,840,000.00
Revenue This Year
N/A
$14.29
Revenue Next Year
$6.43
$16.65
P/E Ratio
N/A
$39.52
Revenue Growth
N/A
35.41
52 Week Low
$3.54
$1.32
52 Week High
$9.10
$3.10

Technical Indicators

Market Signals
Indicator
SRI
PLX
Relative Strength Index (RSI) 77.30 85.33
Support Level $6.37 $2.03
Resistance Level $7.98 $2.11
Average True Range (ATR) 0.45 0.12
MACD 0.19 0.08
Stochastic Oscillator 100.00 94.50

Price Performance

Historical Comparison
SRI
PLX

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

Share on Social Networks: